B3GALNT2
Showing 26 - 50 of >10,000
Pancreatic Ductal Adenocarcinoma Trial (OT-101, FOLFIRINOX)
Not yet recruiting
- Pancreatic Ductal Adenocarcinoma
- (no location specified)
Oct 5, 2023
Pneumococcal Vaccines Trial in Canada (IVT PCV-25 Formulation A, IVT PCV-25 Formulation B, IVT PCV-25 Formulation C)
Not yet recruiting
- Pneumococcal Vaccines
- IVT PCV-25 Formulation A
- +3 more
-
Vancouver, British Columbia, Canada
- +3 more
Oct 10, 2023
Bipolar Disorder Trial in Canada (Cannabidiol, Placebo)
Not yet recruiting
- Bipolar Disorder
- Cannabidiol
- Placebo
-
Calgary, Alberta, Canada
- +7 more
May 18, 2023
Learn About Interferon-beta Exposure of Pregnant Women During
Not yet recruiting
- Multiple Sclerosis (MS)
- Avonex (IFNβ-1-a, Biogen Netherlands B.V)
- +5 more
-
Multiple Locations, Finland
- +1 more
Sep 19, 2023
Diffuse Large B Cell Lymphoma Trial (Epcoritamab, Lenalidomide)
Not yet recruiting
- Diffuse Large B Cell Lymphoma
- Epcoritamab
- Lenalidomide
- (no location specified)
Jan 20, 2023
DLBCL, Grade 3b Follicular Lymphoma, Primary Mediastinal (Thymic) Large B-Cell Lymphoma Trial (biological, procedure, drug,
Not yet recruiting
- Diffuse Large B-Cell Lymphoma
- +6 more
- Axicabtagene Ciloleucel
- +10 more
- (no location specified)
Jan 13, 2023
Anesthesia Trial in Halifax, Montréal (memsorb)
Recruiting
- Anesthesia
- memsorb
-
Halifax, Nova Scotia, Canada
- +1 more
Nov 18, 2022
Diffuse Large B Cell Lymphoma, Primary Mediastinal Large B Cell Lymphoma, Large B-cell Lymphoma Trial in Kaohsiung, Taipei
Recruiting
- Diffuse Large B Cell Lymphoma
- +4 more
- CD19-targeted chimeric antigen receptor T-cell
-
Kaohsiung, Taiwan
- +2 more
Oct 25, 2022
MT2017-45: CAR-T Cell Therapy for Heme Malignancies
Recruiting
- Acute Lymphoblastic Leukemia
- Large B-cell Lymphoma
- KYMRIAH
- +8 more
-
Minneapolis, MinnesotaMasonic Cancer Center at University of Minnesota
Nov 2, 2022
Contraception, Prevention of Sexually Transmitted Infections Trial in Los Angeles (Control Latex Condom C, Polyurethane Condom
Completed
- Contraception
- Prevention of Sexually Transmitted Infections
- Control Latex Condom C, Polyurethane Condom A, Polyurethane Condom B
-
Los Angeles, CaliforniaEssential Access Health
Feb 28, 2023
Malaria,Falciparum Trial in Bamako (MSP3-CRM-Vac4All/ Alhydrogel®, Anti-Rabies Vaccine)
Not yet recruiting
- Malaria,Falciparum
- MSP3-CRM-Vac4All/ Alhydrogel®
- Anti-Rabies Vaccine
-
Bamako, MaliMalaria Research and Training Center (MRTC), University of Scien
Mar 7, 2023
COVID-19 Trial in Adelaide (Advax-CpG55.2 adjuvanted recombinant spike protein)
Recruiting
- COVID-19
- Advax-CpG55.2 adjuvanted recombinant spike protein
-
Adelaide, South Australia, AustraliaARASMI
Aug 15, 2022
Advanced Solid Tumors Trial in Australia, Korea, Republic of, Thailand (YBL-006)
Active, not recruiting
- Advanced Solid Tumors
-
Macquarie, New South Wales, Australia
- +6 more
Dec 1, 2022
B Acute Lymphoblastic Leukemia Trial (procedure, biological, drug, radiation)
Not yet recruiting
- B Acute Lymphoblastic Leukemia
- Biospecimen Collection
- +19 more
- (no location specified)
Nov 8, 2023
Virus Diseases Trial in London (ConM SOSIP 50 ug and ConS UFO 50 ug, Mos3.1 100 ug, Mos3.2 100 ug)
Active, not recruiting
- Virus Diseases
- ConM SOSIP 50 ug and ConS UFO 50 ug
- +4 more
-
London, Please Select..., United KingdomNIHR Imperial Clinical Research Facility
Jul 25, 2022
SARS-CoV-2 Infection, COVID-19 Trial in Australia, New Zealand (BNT162b2, Placebo, Seasonal Inactivated Influenza Vaccine)
Completed
- SARS-CoV-2 Infection
- COVID-19
- BNT162b2
- +2 more
-
Brookvale, New South Wales, Australia
- +25 more
Nov 22, 2023
SARS-CoV-2 Infection, COVID-19 Trial in Australia, New Zealand (BNT162b2, Placebo, Seasonal Inactivated Influenza Vaccine)
Completed
- SARS-CoV-2 Infection
- COVID-19
- BNT162b2
- +2 more
-
Brookvale, New South Wales, Australia
- +25 more
Nov 13, 2023
Amyotrophic Lateral Sclerosis Trial in Fredericton, Montréal (Reldesemtiv)
Recruiting
- Amyotrophic Lateral Sclerosis
-
Fredericton, New Brunswick, Canada
- +1 more
Aug 9, 2022
DLBCL, Not Otherwise Specified, Recurrent DLBCL, Recurrent Primary Mediastinal (Thymic) Large B-Cell Lymphoma Trial in Seattle
Terminated
- Diffuse Large B-Cell Lymphoma, Not Otherwise Specified
- +5 more
- Autologous Anti-CD19CAR-4-1BB-CD3zeta-EGFRt-expressing CD4+/CD8+ Central Memory T-lymphocytes JCAR014
- +3 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Aug 1, 2022
HLA-A2 Positive Cells Present, Refractory Melanoma Trial in Buffalo (Alpha-type-1 Polarized Dendritic Cells, Celecoxib, PD-1
Recruiting
- HLA-A2 Positive Cells Present
- Refractory Melanoma
- Alpha-type-1 Polarized Dendritic Cells
- +5 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Dec 12, 2022
MALT, Nodal Marginal Zone B-cell Lymphoma, Recurrent Grade 1 Follicular Lymphoma Trial in Atlanta, Columbus (drug, biological,
Completed
- Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue
- +8 more
- PI3K inhibitor BKM120
- +3 more
-
Atlanta, Georgia
- +1 more
Jun 27, 2022
Abdominal Aortic Aneurysm (AAA), No Abdominal Aortic Aneurysm (Non-AAA) Trial in Saint Louis (AAA Group (Aim 3A), Non-AAA Group,
Recruiting
- Abdominal Aortic Aneurysm (AAA)
- No Abdominal Aortic Aneurysm (Non-AAA)
- AAA Group (Aim 3A)
- +4 more
-
Saint Louis, MissouriWashington University School of Medicine
Jul 11, 2022
Exercise-Induced Lactic Acidemia Trial in Saskatoon (Beta-alanine, Maltodextrin)
Recruiting
- Exercise-Induced Lactic Acidemia
- Beta-alanine
- Maltodextrin
-
Saskatoon, Saskatchewan, CanadaUniversity of Saskatchewan
Mar 14, 2023
Covid19 Trial in Miami (BNT162b2 vaccine, JNJ-78436735 Vaccine)
Active, not recruiting
- Covid19
- BNT162b2 vaccine
- JNJ-78436735 Vaccine
-
Miami, FloridaUniversity of Miami
Aug 1, 2022